BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38195220)

  • 1. Clinicopathological analysis of BRAF and non-BRAF MAPK pathway-altered gliomas in paediatric and adult patients: a single-institution study of 40 patients.
    Ali RH; Almanabri M; Ali NY; Alsaber AR; Khalifa NM; Hussein R; Alateeqi M; Mohammed EMA; Jama H; Almarzooq A; Benobaid N; Alqallaf Z; Ahmed AA; Bahzad S; Almurshed M
    J Clin Pathol; 2024 Jan; ():. PubMed ID: 38195220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology.
    Qaddoumi I; Orisme W; Wen J; Santiago T; Gupta K; Dalton JD; Tang B; Haupfear K; Punchihewa C; Easton J; Mulder H; Boggs K; Shao Y; Rusch M; Becksfort J; Gupta P; Wang S; Lee RP; Brat D; Peter Collins V; Dahiya S; George D; Konomos W; Kurian KM; McFadden K; Serafini LN; Nickols H; Perry A; Shurtleff S; Gajjar A; Boop FA; Klimo PD; Mardis ER; Wilson RK; Baker SJ; Zhang J; Wu G; Downing JR; Tatevossian RG; Ellison DW
    Acta Neuropathol; 2016 Jun; 131(6):833-45. PubMed ID: 26810070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MYB upregulation and genetic aberrations in a subset of pediatric low-grade gliomas.
    Tatevossian RG; Tang B; Dalton J; Forshew T; Lawson AR; Ma J; Neale G; Shurtleff SA; Bailey S; Gajjar A; Baker SJ; Sheer D; Ellison DW
    Acta Neuropathol; 2010 Dec; 120(6):731-43. PubMed ID: 21046410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-occurrence of histone H3 K27M and BRAF V600E mutations in paediatric midline grade I ganglioglioma.
    Pagès M; Beccaria K; Boddaert N; Saffroy R; Besnard A; Castel D; Fina F; Barets D; Barret E; Lacroix L; Bielle F; Andreiuolo F; Tauziède-Espariat A; Figarella-Branger D; Puget S; Grill J; Chrétien F; Varlet P
    Brain Pathol; 2018 Jan; 28(1):103-111. PubMed ID: 27984673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic alterations related to BRAF-FGFR genes and dysregulated MAPK/ERK/mTOR signaling in adult pilocytic astrocytoma.
    Pathak P; Kumar A; Jha P; Purkait S; Faruq M; Suri A; Suri V; Sharma MC; Sarkar C
    Brain Pathol; 2017 Sep; 27(5):580-589. PubMed ID: 27608415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel RAF Fusions in Pediatric Low-Grade Gliomas Demonstrate MAPK Pathway Activation.
    Lind KT; Chatwin HV; DeSisto J; Coleman P; Sanford B; Donson AM; Davies KD; Willard N; Ewing CA; Knox AJ; Mulcahy Levy JM; Gilani A; Green AL
    J Neuropathol Exp Neurol; 2021 Dec; 80(12):1099-1107. PubMed ID: 34850053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of disseminated pilocytic astrocytomas.
    Gessi M; Engels AC; Lambert S; Rothämel T; von Hornstein S; Collins VP; Denkhaus D; Gnekow A; Pietsch T
    Neuropathol Appl Neurobiol; 2016 Apr; 42(3):273-8. PubMed ID: 26084390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and molecular characterization of a multi-institutional cohort of pediatric spinal cord low-grade gliomas.
    Grob ST; Nobre L; Campbell KR; Davies KD; Ryall S; Aisner DL; Hoffman L; Zahedi S; Morin A; Crespo M; Nellan A; Green AL; Foreman N; Vibhakar R; Hankinson TC; Handler MH; Hawkins C; Tabori U; Kleinschmidt-DeMasters BK; Mulcahy Levy JM
    Neurooncol Adv; 2020; 2(1):vdaa103. PubMed ID: 33063010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-grade epilepsy-associated neuroepithelial tumours with a prominent oligodendroglioma-like component: The diagnostic challenges.
    Métais A; Appay R; Pagès M; Gallardo C; Silva K; Siegfried A; Perbet R; Maurage CA; Scavarda D; Fina F; Uro-Coste E; Riffaud L; Colin C; Figarella-Branger D;
    Neuropathol Appl Neurobiol; 2022 Feb; 48(2):e12769. PubMed ID: 34551121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosome band 7q34 deletions resulting in KIAA1549-BRAF and FAM131B-BRAF fusions in pediatric low-grade Gliomas.
    Roth JJ; Santi M; Pollock AN; Harding BN; Rorke-Adams LB; Tooke LS; Biegel JA
    Brain Pathol; 2015 Mar; 25(2):182-92. PubMed ID: 25040262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of the FGFR1 mutation with spontaneous hemorrhage in low-grade gliomas in pediatric and young adult patients.
    Ishi Y; Yamaguchi S; Hatanaka KC; Okamoto M; Motegi H; Kobayashi H; Terasaka S; Houkin K
    J Neurosurg; 2020 Feb; 134(3):733-741. PubMed ID: 32059187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pediatric Glioma].
    Terashima K; Ogiwara H
    No Shinkei Geka; 2021 May; 49(3):640-646. PubMed ID: 34092570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ROS1 Alterations as a Potential Driver of Gliomas in Infant, Pediatric, and Adult Patients.
    Meredith DM; Cooley LD; Dubuc A; Morrissette J; Sussman RT; Nasrallah MP; Rathbun P; Yap KL; Wadhwani N; Bao L; Wolff DJ; Ida C; Sukhanova M; Horbinski C; Jennings LJ; Farooqi M; Gener M; Ginn K; Kam KL; Sasaki K; Kanagal-Shamanna R; Alexandrescu S; Brat D; Lu X
    Mod Pathol; 2023 Nov; 36(11):100294. PubMed ID: 37532182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Alterations in Pediatric Low-Grade Gliomas That Led to Death.
    Ahrendsen JT; Sinai C; Meredith DM; Malinowski SW; Cooney TM; Bandopadhayay P; Ligon KL; Alexandrescu S
    J Neuropathol Exp Neurol; 2021 Nov; 80(11):1052–1059. PubMed ID: 34580728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphous Low-Grade Neuroepithelial Tumor of the Young (PLNTY): Molecular Profiling Confirms Frequent MAPK Pathway Activation.
    Ida CM; Johnson DR; Nair AA; Davila J; Kollmeyer TM; Minn K; Fadra NM; Balcom JR; Fung KA; Kim DK; Kaufmann TJ; Kipp BR; Halling KC; Jenkins RB; Giannini C
    J Neuropathol Exp Neurol; 2021 Sep; 80(9):821-829. PubMed ID: 34363682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KIAA1549-BRAF fusions and IDH mutations can coexist in diffuse gliomas of adults.
    Badiali M; Gleize V; Paris S; Moi L; Elhouadani S; Arcella A; Morace R; Antonelli M; Buttarelli FR; Figarella-Branger D; Kim YH; Ohgaki H; Mokhtari K; Sanson M; Giangaspero F
    Brain Pathol; 2012 Nov; 22(6):841-7. PubMed ID: 22591444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paediatric Gliomas: BRAF and Histone H3 as Biomarkers, Therapy and Perspective of Liquid Biopsies.
    Tan JY; Wijesinghe IVS; Alfarizal Kamarudin MN; Parhar I
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33557011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive Genomic Profiling of 282 Pediatric Low- and High-Grade Gliomas Reveals Genomic Drivers, Tumor Mutational Burden, and Hypermutation Signatures.
    Johnson A; Severson E; Gay L; Vergilio JA; Elvin J; Suh J; Daniel S; Covert M; Frampton GM; Hsu S; Lesser GJ; Stogner-Underwood K; Mott RT; Rush SZ; Stanke JJ; Dahiya S; Sun J; Reddy P; Chalmers ZR; Erlich R; Chudnovsky Y; Fabrizio D; Schrock AB; Ali S; Miller V; Stephens PJ; Ross J; Crawford JR; Ramkissoon SH
    Oncologist; 2017 Dec; 22(12):1478-1490. PubMed ID: 28912153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diagnostic role and clinical relevance of determination of BRAF status in brain tumors.
    Gessi M; Pietsch T
    Per Med; 2013 Jun; 10(4):405-412. PubMed ID: 29783415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRAF alterations in primary glial and glioneuronal neoplasms of the central nervous system with identification of 2 novel KIAA1549:BRAF fusion variants.
    Lin A; Rodriguez FJ; Karajannis MA; Williams SC; Legault G; Zagzag D; Burger PC; Allen JC; Eberhart CG; Bar EE
    J Neuropathol Exp Neurol; 2012 Jan; 71(1):66-72. PubMed ID: 22157620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.